Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tangshenkang is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Gansu Provincial Hospital of TCM, specifically designed for the treatment of diabetic nephropathy (DN). Administered as a capsule, it is utilized in clinical settings to treat patients in the III or IV stages of DN, aiming to improve renal function, reduce proteinuria, and manage the progression of kidney damage associated with type 2 diabetes mellitus. The therapeutic approach of Tangshenkang is rooted in TCM principles, targeting Qi deficiency and blood stasis to provide renoprotective effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tangshenkang.